LPC

Lion Point Capital Portfolio holdings

AUM $14.7M
1-Year Est. Return 16.78%
This Quarter Est. Return
1 Year Est. Return
+16.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$31.9M
AUM Growth
-$20.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
32
New
Increased
Reduced
Closed

Top Buys

1
+$1.24M
2
+$222K
3
+$127K
4
NBIX icon
Neurocrine Biosciences
NBIX
+$117K
5
MIST icon
Milestone Pharmaceuticals
MIST
+$52.8K

Top Sells

1
+$1.41M
2
+$731K
3
+$601K
4
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$485K
5
REPL icon
Replimune Group
REPL
+$347K

Sector Composition

1 Healthcare 87.47%
2 Financials 2.69%
3 Consumer Discretionary 1.75%
4 Technology 0.14%
5 Energy 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$6.35M 11.57%
856,667
-190,000
2
$4.71M 8.59%
70,335
3
$3.09M 5.63%
2,340,207
+40,000
4
$2.67M 4.87%
630,000
+30,000
5
$2.47M 4.51%
2,114,827
-4,309
6
$1.95M 3.56%
104,691
-26,000
7
$1.33M 2.43%
65,000
8
$1.24M 2.26%
+49,000
9
$1.16M 2.11%
82,500
10
$1.15M 2.1%
8,350
+850
11
$1.04M 1.89%
170,000
12
$924K 1.69%
79,000
+19,000
13
$858K 1.56%
78,125
14
$726K 1.32%
32,000
15
$668K 1.22%
33,913
-8,500
16
$557K 1.02%
2,745,938
17
$424K 0.77%
36,250
+3,750
18
$247K 0.45%
17,038
19
$211K 0.38%
90,794
20
$44.7K 0.08%
100
21
$38.8K 0.07%
75,000
22
$26.3K 0.05%
2,083,438
23
$24.8K 0.05%
7,423
-12,503
24
$18.3K 0.03%
100
25
– –
-235,000
1
2